Endothelin A Receptor Antagonists

Preferred Label : Endothelin A Receptor Antagonists;

MeSH definition : Compounds and drugs that bind to and inhibit or block the activation of ENDOTHELIN A RECECPTORS.;

MeSH synonym : Blockers, Endothelin A Receptor; Endothelin Type A Receptor Antagonists; Antagonists, Endothelin A Receptor; Endothelin A Receptor Blockers;

Is substance : O;

Détails

Origin ID

D065130;

UMLS CUI

C1516869;

Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- analysis [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Currated CISMeF NLP mapping
- Endothelin Receptor Type A Antagonist [NCIt concept]
MeSH Descriptor(s) used for indexing
- receptor, endothelin a [MeSH Descriptor]
Record concept(s)
- Endothelin A Receptor Antagonists [MeSH concept]
See also inter- (CISMeF)
- Endothelin receptor antagonist (disposition) [SNOMED CT concept]
Semantic type(s)
- Pharmacologic Substance [UMLS semantic type]
Substance(s)
- 2-(butyryl-(2'-(4,5-dimethylisoxazol-3-ylsulfamoyl)biphenyl-4-ylmethyl)amino)-N-isopropyl-3-methylbutyramide [MeSH Supplementary Concept]
- 2-(butyryl-(2'-(4-chloro-5-methylisoxazol-3-ylsulfamoyl)biphenyl-4-ylmethyl)amino)-N-isopropyl-3-methylbutyramide [MeSH Supplementary Concept]
- 2-(butyryl-(2'-(4-fluoro-5-methylisoxazol-3-ylsulfamoyl)biphenyl-4-ylmethyl)amino)-N-isopropyl-3-methylbutyramide [MeSH Supplementary Concept]
- 3-azabicyclo(3.2.1)octan-1-yl-leucyl-tryptophyl-4-chlorophenylalanine [MeSH Supplementary Concept]
- Atrasentan [MeSH Descriptor]
- HJP 278 [MeSH Supplementary Concept]
- HJP 286 [MeSH Supplementary Concept]
- N-(2-acetyl-4,6-dimethylphenyl)-3-(3,4-dimethylisoxazol-5-ylsulfamoyl)thiophene-2-carboxamide [MeSH Supplementary Concept]
- di-n-butylaminocarbamyl-leucyl-tryptophyl-4-chlorophenylalanine [MeSH Supplementary Concept]
- macitentan [MeSH Supplementary Concept]
UMLS correspondences (same concept)
- Endothelin Receptor Type A Antagonist [NCIt concept]
Validated automatic mappings to NTBT
- Endothelin Receptor Antagonist [NCIt concept]
- Substance with endothelin receptor antagonist mechanism of action (substance) [SNOMED CT concept]

Position du mot-clé dans l'(les) arborescence(s) :

Vous pouvez consulter :

recommendations
documents concerning education
documents for patients